Monday, 15 October 2018
These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them?

Added: 11.10.2018 1:19 | 20 views | 0 comments

Source: seekingalpha.com
Source: seekingalpha.com

Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.

More in www.nytimes.com »

Tags: PC



Image with code
CommentsComments:
advertising

Copyright © 2008 - 2018 USweekly  - all rights reserved